Sharp Therapeutics (TSXV:SHRX) General and Admin. Expense: C$2.57 Mil (TTM As of Dec. 2025)


TSXV:SHRX Sharp Therapeutics Corp TSXV:SHRX
15 GF Score
Price C$0.91
View Full Analysis

What is Sharp Therapeutics General and Admin. Expense?

Sharp Therapeutics TSXV:SHRX 15 General and Admin. Expense is C$2.57 Mil as of Dec. 2025. GuruFocus rates TSXV:SHRX with a GF Score™ of 15/100.

General and Admin. Expense is the aggregate total of general managing and administering expenses for the company. Sharp Therapeutics's General and Admin. Expense for the three months ended in Dec. 2025 was C$0.98 Mil. Its General and Admin. Expense for the trailing twelve months (TTM) ended in Dec. 2025 was C$2.57 Mil.

Sharp Therapeutics General and Admin. Expense Related Terms

Sharp Therapeutics General and Admin. Expense Historical Data

* Premium members only.

The historical data trend for Sharp Therapeutics's General and Admin. Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sharp Therapeutics General and Admin. Expense Chart

Sharp Therapeutics Annual Data
Trend Dec23 Dec24 Dec25
General and Admin. Expense
0.52 0.47 2.55

Sharp Therapeutics Quarterly Data
Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
General and Admin. Expense Get a 7-Day Free Trial Premium Member Only -0.68 0.56 0.59 0.44 0.98
TSXV:SHRX
15GF Score
Sharp Therapeutics Corp TSXV:SHRX
General and Admin. Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Sharp Therapeutics General and Admin. Expense Calculation

General and Admin. Expense is the aggregate total of general managing and administering expenses for the company.

General and Admin. Expense for the trailing twelve months (TTM) ended in Dec. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was C$2.57 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a General and Admin. Expense of C$2.57 Mil mean?
Sharp Therapeutics (TSXV:SHRX) has a General and Admin. Expense of C$2.57 Mil as of Dec. 2025. General and Admin. Expense is the aggregate total of general managing and administering expenses for the company. View historical data on Sharp Therapeutics and its competitors.
Is Sharp Therapeutics' General and Admin. Expense too high?
Sharp Therapeutics' current General and Admin. Expense is C$2.57 Mil. Overall, Sharp Therapeutics has a GF Score™ of 15/100, reflecting its overall financial health beyond just this single metric.
How does Sharp Therapeutics' General and Admin. Expense compare to VRTX and REGN?
Sharp Therapeutics' General and Admin. Expense of C$2.57 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good General and Admin. Expense for a Biotechnology company?
A good General and Admin. Expense depends on the Biotechnology industry context. However, General and Admin. Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high General and Admin. Expense mean?
A high General and Admin. Expense can signal that a stock is expensive relative to its fundamentals. General and Admin. Expense is the aggregate total of general managing and administering expenses for the company. View historical data on Sharp Therapeutics and its competitors. Sharp Therapeutics's current General and Admin. Expense is C$2.57 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sharp Therapeutics stock overvalued right now?
Sharp Therapeutics (TSXV:SHRX) has a current General and Admin. Expense of C$2.57 Mil. The current General and Admin. Expense is C$2.57 Mil. Sharp Therapeutics' overall GF Score™ is 15/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is General and Admin. Expense calculated?
General and Admin. Expense is calculated from a company's financial statements. For Sharp Therapeutics (TSXV:SHRX), the current General and Admin. Expense is C$2.57 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Sharp Therapeutics Business Description

Address 2403 Sidney Street, Suite 264, Pittsburgh, PA, USA, 15203
Sharp Therapeutics Corp is a preclinical-stage drug discovery company developing therapeutics for genetic diseases. It has developed the patent-protected Disco discovery platform consisting of the CoreX biology, AlloChem chemistry, and Mine computational technologies to discover drugs that selectively activate the protein thats been altered by gene mutation. The company has targeted its discovery engine (Disco) to three hereditary disorders with high unmet need, which include Gauchers Disease, Familial Frontotemporal Dementia, and Niemann Pick Type-C. Its drug development pipeline consists of the following candidates: SEL-148, 721, SEL-148, 742, and SEL-145, 793. Geographically, the company's business operations are carried out in the United States of America.
15GF Score

Get the complete analysis for TSXV:SHRX

General and Admin. Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

C$0.91
Price